Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1/2
×
Pathologic Complete Response
×
Other hematologic neoplasm
×
Clear all
Filters
3
NCT02789254
2023-12-28
FLYSYN-101
Synimmune GmbH
Phase 1/2
Completed
31 enrolled
NCT01656252
2020-11-03
PrE0901
PrECOG, LLC.
Phase 1/2
Terminated
15 enrolled
5 charts